The UK Antimicrobial Resistance (AMR) Diagnostic Collaborative (UK ADC) on behalf ofEngland is undertaking a focussed piece of work on the Blood Culture Pathway. This work forms one of the key focus areas of the UK ADC as part of the Government’s response to AMR. Professor Dame Sally Davies, CMO for England has overseen a strategy consisting of a tripartite approach; PREVENT- infection prevention and control, PROMOTE the development of new antimicrobials, PRESERVE existing antibiotics through stewardship and better use of existing and new diagnostics.
With support from a working group of experts from across the system, the UK ADC has developed a survey. The aim of the survey is to gain a system wide understanding of current laboratory practice in relation to quality and unwarranted variation. Gaining a system wide understanding of current practice will enable the UK ADC and key system partners to develop mechanisms to improve services. Antimicrobial resistance is a major challenge to healthcare worldwide, it is essential that all hospitals / laboratories complete the survey to both help shape diagnostic services and help preserve antibiotics for the future.
- Whist names of organisations / individuals are requested any data emerging from this survey will be anonymised to prevent it being traced back to an individual / hospital / organisation.
- Where good / novel practice exists, or individuals raise concerns we would like the facility to be able to contact them to learn more, any discussions being confidential.
England ask that, a senior healthcare scientist, works to ensure a single coordinated response from the most appropriate individual who can address the blood culture pathway locally. England are seeking an understanding of practice systemwide and require a response covering all hospitals including those who have off-site laboratories.
Please share the survey link locally: https://www.snapsurveys.com/wh/s.?k=154325196841
Please note this survey will close on Friday 11th January 2019.